![]() |
Associate Professor |
| Bio |
Background Information
Dr. Lejuez received his Ph.D. in 2000 from West Virginia University. After serving as an Assistant Professor (Research) at the Brown Medical School, he joined the Clinical Psychology Program at the University of Maryland in 2001 and was promoted to Associate Professor in 2005. He has published over 100 articles, books, and book chapters, served as PI for over $7 million in grant funding, and was awarded Young Investigator Awards from the American Psychological Association Division of Experimental Psychology (Applied) and the Association for Behavioral and Cognitive Therapies (ABCT, formerly AABT).
Dr. Lejuez's current clinical and research interests focus on the development of ecologically valid laboratory analogues of addiction and their use to better understand the active ingredients of treatment (i.e., translational research). His most recent projects involve (1) the creation and validation of a behavioral task to predict adolescent risk-taking behaviors (e.g., drug use, unsafe sexual practices), with the extension of this work to include the role of neurobehavioral, biological, and environmental variables; (2) the examination of factors underlying addictions treatment failure (e.g., low distress tolerance); and (3) the treatment of depression using behavioral activation strategies, and the application of the work to other conditions co-morbid with depression (e.g., substance use, physical illness).
In the past 6 years Dr. Lejuez has served as the primary mentor for 15 graduate students. Nine have either received their PhD or are currently on internship, with an average number of publications greater than 6 and multiple grants awarded from NIH (3 NRSA’s, 2 minority supplements, and 2 Dissertations R36). All students have placed at an internship in their first year through the match process including placements at Brown University (2), Yale University, Seattle VA, Albuquerque VA, Robert Wood Johnson, Children’s National Medical Center DC, and the Baltimore VA/University of Maryland, Baltimore Consortium (2). At an undergraduate level, he has served as the primary research advisor for over 40 students, with students going on to seek graduate degrees in areas such as public health, social work, and hospital administration, and several moving on to Ph.D. Programs in Clinical Psychology (e.g., UCLA, University of Pittsburgh, University of Tennessee). He has served as the mentor for Psi Chi (The Undergraduate Psychology Honor Society) over the past 4 years. Speaking to his commitment to graduate and undergraduate student development, he was awarded the College of Behavioral and Social Sciences Mentorship and Teaching Award for 2006.
Selected Publications
Hopko, D. R., & Lejuez, C. W. (in press). A Cancer Patient's Guide to Overcoming Depression & Anxiety: Getting Through Treatment and Getting Back to Your Life. New Harbinger: Oakland, CA.
Lejuez, C. W., Aklin, W. M., Daughters, S. B., Zvolensky, M. J., Kahler, C. W., & Gwadz, M. (2007). Reliability and validity of the youth version of the Balloon Analogue Risk Task (BART-Y) in the assessment of risk-taking behavior among inner-city adolescents. Journal of Clinical Child and Adolescent Psychology, 36, 106-111.
Lejuez, C.W.,
Hopko, D. R., Levine, S., Gholkar, R., & Collins, L. M. (2006). The Therapeutic
Alliance in Behavior Therapy. Psychotherapy: Theory, Research, Practice,
Training, 42, 456-468.
Lejuez, C. W., Paulson, A., Daughters, S. B., Bornovalova, M. A., Zvolensky, M.
J. (2006). The association between heroin use and anxiety sensitivity among
inner-city individuals in residential drug use treatment. Behaviour Research
and Therapy, 44, 667-677.
Lejuez, C. W., Bornovalova, M., Daughters, S. B., & Curtin, J. J. (2005).
Differences in impulsivity and sexual risk-taking behavior among inner-city
crack/cocaine and heroin users. Drug and Alcohol Dependence, 77, 169-175.
Wallsten, T. W, Pleskac, T., & Lejuez, C. W. (2005). Cognitive modeling of a
sequential risk-taking task. Psychological Review, 112, 862-880.
Selected Grants
“Drug Choice, Impulsivity, and Risky Sexual Behavior”
Principal Investigator: Carl W. Lejuez, Ph.D.
Agency and Type: National Institute of Drug Abuse R01
Type and Number: R01 DA19405
Period: 6/01/06 – 5/31/10
Total Costs = $1,250,000
“Behavioral Treatment for Depressed Smokers”
Principal Investigator: Carl W. Lejuez, Ph.D.
Agency: National Institute of Drug Abuse R01
Type and Number: R01 DA18730
Period: 10/01/05 – 6/30/08
Total Costs = $1,100,000
“Behavioral Technologies for Predicting HIV Risk”
Principal Investigator: Carl W. Lejuez, Ph.D.
Agency: National Institute of Drug Abuse
Type and Number: R01 DA18647
Period: 7/1/05-6/30/10
Total Costs = $1,640,000
“Behavioral Technologies for Predicting HIV Risk: Genetics Administrative Supplement”
Principal Investigator: Carl W. Lejuez, Ph.D.
Agency: National Institute of Drug Abuse
Type and Number: R01 DA18647-S2
Period: 9/1/06-6/30/10
Total Costs = $196,000
“Distress Tolerance and Early Smoking Lapse”
Principal Investigator: Carl W. Lejuez, Ph.D.
Agency: National Institute of Drug Abuse
Type and Number: R01 DA15375
Period: 8/15/03 – 5/31/07
Total Costs = $869,000
“Distress Tolerance and Early Smoking Lapse: Cortisol Administrative Supplement”
Principal Investigator: Carl W. Lejuez, Ph.D.
Agency: National Institute of Drug Abuse
Type and Number: R01 DA15375-S2
Period: 8/15/05 – 5/31/07
Total Costs = $74,500
“Testing a Behavioral Predictor of HIV Risk”
Principal Investigator: Carl W. Lejuez, Ph.D.
Agency: National Institute of Drug Abuse
Type and Number: R21 DA14699
Period: 10/1/02 – 9/30/05
Total Costs = $289,000